Lung Basic Panel By NGS [EGFR, ALK, ROS1, BRAF,MET (SNVs & Indels)51+ booked in last 3 days
The Lung Basic Panel by NGS (Next-Generation Sequencing) is a diagnostic test that uses advanced sequencing technology to detect specific genetic alterations in Non-Small Cell Lung Carcinoma (NSCLC). The panel focuses on genetic alterations in genes including EGFR, ALK, ROS1, BRAF, and MET, specifically targeting single nucleotide variants (SNVs) and insertions/deletions (Indels). These genetic alterations are known to play a significant role in the development and progression of NSCLC. The NGS-based panel provides comprehensive genetic information about the tumor, helping clinicians make informed decisions regarding treatment options, such as targeted therapies or immunotherapies. It aids in personalized medicine approaches and improves patient outcomes by identifying potential actionable mutations in NSCLC.
Lung Basic Panel By NGS [EGFR, ALK, ROS1, BRAF,MET (SNVs & Indels) Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Lung Basic Panel By NGS [EGFR, ALK, ROS1, BRAF,MET (SNVs & Indels) with a clear pricing structure.
The Lung Basic Panel By NGS [EGFR, ALK, ROS1, BRAF,MET (SNVs & Indels) Price in Mumbai is ₹ 34,560 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
The Lung Basic Panel detects genetic alterations in genes including EGFR, ALK, ROS1, BRAF, and MET, specifically targeting single nucleotide variants (SNVs) and insertions/deletions (Indels) in lung tissue to identify the presence of Non-Small Cell Lung Carcinoma (NSCLC).
• To aid in the diagnosis and subtyping of NSCLC • To guide treatment decisions based on genetic and molecular characteristics of the cancer cells • To monitor treatment effectiveness and disease progression • To assess prognosis and predict patient outcomes
The Lung Basic Panel is recommended for individuals who • have been diagnosed with or suspected to have NSCLC, • require accurate subtyping of NSCLC for effective treatment planning, • need to monitor treatment response or disease progression, or • want to understand their prognosis and predicted outcomes.
If the results of the Lung Basic Panel are abnormal, it may indicate the presence of NSCLC or provide insights into specific genetic mutations or molecular changes that can guide targeted therapies.
During the test, a small tissue sample (FFPE block) containing lung tumour cells will be drawn. The sample will be sent to the laboratory for analysis.
• Provide a clinical history with Histopath/IHC report along with the doctor's contact number. • Inform your doctor if you have any specific requirements.
• Immunohistochemistry (IHC) testing: IHC helps determine specific protein expression patterns in lung tissue, aiding in subtyping NSCLC. • Molecular testing: Molecular tests analyse specific genetic mutations or alterations, guiding targeted therapy decisions.
Non-Small Cell Lung Carcinoma (NSCLC) Panel
Non-Small Cell Lung Carcinoma is a type of lung cancer that accounts for around 80% of all lung cancer cases. It includes several subtypes, such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
Ratings & Reviews (0)
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.